The tweet was deleted by the author.
But we saved everything 🙂.
Pacific Biosciences of California is hosting a webinar to explore how long-read multiomics is transforming human disease research.
The event will address how leading scientists are combining genomic, epigenomic, and proteomic data to drive progress in rare disease understanding, neurodegeneration studies, and AI-powered drug discovery. The company aims to highlight innovation at the intersection of multiomics and healthcare, supporting the next wave of research and therapeutic development.
View post on X Loading...
Earlier this year, Pacific Biosciences of California propelled T2T genomics as the journal Cell published a special issue featuring 13 new complete genome assemblies here. The company has also analyzed Illumina TruPath against PacBio HiFi whole genome sequencing, focusing on benchmarking, variant calling, and phasing here. These efforts highlight Pacific Biosciences’ continued activity in genomic technology development.